Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Futu Holdings Ltd (FUTU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Futu Holdings Ltd — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.3 (market cap $4.02B), while Futu Holdings Ltd trades at $107.39 (market cap $15.35B). The key difference: Futu Holdings Ltd is far larger — about 3.8× Edgewise Therapeutics Inc. Common Stock's market cap, and Futu Holdings Ltd pays a 2.37% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Futu Holdings Ltd for 34 Days on average.
| EWTX | FUTU | |
|---|---|---|
Market Cap | $4.02B | $15.35B |
Volume | 1,446,128 | 1,329,666 |
Sector | Health | Financials |
52-Week High | $48.35 | $199.04 |
52-Week Low | $14.89 | $89.76 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $3.56B | $15.69B |
Dividend Yield | — | 2.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Futu Holdings trades at $114.06, up 1.6% today, with a neutral technical signal and bullish moving averages. The company reported strong revenue growth, with 2025 revenue reaching $22.85 billion and net income of $11.34 billion, though Q1 2026 earnings missed expectations. Analyst sentiment is positive with a 58.34% buy rating, and recent news highlights expansion initiatives like the Moomoo platform's partnership with X's Cashtag program.
The outlook for Futu is cautiously optimistic, supported by robust profitability and overseas growth potential, but risks include ongoing class-action lawsuits and earnings volatility. Wall Street sees a 33.7% upside potential, making it attractive for growth-oriented investors despite regulatory and competitive headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Futu Holdings Ltd
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.
Read more on FUTU →
